capsaicin 0.000325 MG/MG / lidocaine 0.045 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment

RxCUI
1361410
RxNorm name
capsaicin 0.000325 MG/MG / lidocaine 0.045 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment
Display name
Capsaicin/Lidocaine/Menthol/Methyl salicylate (Topical)
Full name
capsaicin 0.000325 MG/MG / lidocaine 0.045 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment
Term type
SCD
Status
Active
Strength
0.0325-4.5-10-27.5%
Dose form
Ointment
Route
Topical
Updated
2026-07-24 06:53:08

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012013
Active start
012013
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
capsaicin0.000325 MG / 1 MGcapsaicincapsaicin
methyl salicylate0.275 MG / 1 MGmethyl salicylatemethyl salicylate
lidocaine0.045 MG / 1 MGlidocainelidocaine
menthol0.1 MG / 1 MGmentholmenthol

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Ointment316985

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
capsaicin1992
methyl salicylate29787
lidocaine6387
menthol6750

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
53217004801rxnav_historical
53225102101rxnav_historical
54569651200rxnav_historical

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCM02ABCapsaicin and similar agentsATC1-4capsaicin
ATCC05ADLocal anestheticsATC1-4lidocaine
ATCS01HALocal anestheticsATC1-4lidocaine
ATCN01BXOther local anestheticsATC1-4capsaicin
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD002211CapsaicinCHEMhas_ingredientcapsaicin
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD008610MentholCHEMhas_ingredientmenthol
MEDRTD012459SalicylatesCHEMhas_ingredientmethyl salicylate
MEDRTD059787Acute PainDISEASEmay_treatmethyl salicylate
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD001168ArthritisDISEASEmay_treatmethyl salicylate
MEDRTD001416Back PainDISEASEmay_treatmethyl salicylate
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD003288ContusionsDISEASEmay_treatmethyl salicylate
MEDRTD003929Diabetic NeuropathiesDISEASEmay_treatcapsaicin
MEDRTD004342Drug HypersensitivityDISEASEci_withcapsaicin
MEDRTD004342Drug HypersensitivityDISEASEci_withmenthol
MEDRTD004342Drug HypersensitivityDISEASEci_withmethyl salicylate
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD006562Herpes ZosterDISEASEmay_treatcapsaicin
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD007249InflammationDISEASEmay_treatmethyl salicylate
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD009120Muscle CrampDISEASEmay_treatmethyl salicylate
MEDRTD009437NeuralgiaDISEASEmay_treatcapsaicin
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_treatmenthol
MEDRTD010146PainDISEASEmay_preventcapsaicin
MEDRTD012871Skin DiseasesDISEASEmay_treatmenthol
MEDRTD013180Sprains and StrainsDISEASEmay_treatmethyl salicylate
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTN0000000069Calcium Channel AntagonistsMOAhas_moamenthol
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moamethyl salicylate
MEDRTN0000000105Neurotransmitter Transporter InteractionsMOAhas_moacapsaicin
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moamethyl salicylate
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pemethyl salicylate
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pecapsaicin
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pementhol
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_pemethyl salicylate
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.000325 MG/MG / 0.045 MG/MG / 0.1 MG/MG / 0.275 MG/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSCD
CODESMMSL_CODECD28564
CODESRxCUI1361410
CODESVUID4032149
NAMESPrescribable Synonymcapsaicin 0.0325 % / lidocaine 4.5 % / menthol 10 % / methyl salicylate 27.5 % Topical Ointment
NAMESRXNAV_STRcapsaicin 0.000325 MG/MG / lidocaine 0.045 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment
NAMESRxNorm Namecapsaicin 0.000325 MG/MG / lidocaine 0.045 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment
NAMESRxNorm Synonymcapsaicin 0.0325 % / lidocaine 4.5 % / menthol 10 % / methyl salicylate 27.5 % Topical Ointment
SOURCESSourceVeterans Health Administration National Drug File